Defibrillation efficacy of a subcutaneous array lead: A case report

Summary We report a case of Brugada syndrome with a high defibrillation threshold (DFT) in whom a subcutaneous array lead was used to lower the DFT in combination with a transvenous right ventricular defibrillation lead. The patient had previously received pacemaker implantation due to sick sinus sy...

Full description

Saved in:
Bibliographic Details
Published inJournal of cardiology cases Vol. 1; no. 1; pp. e21 - e24
Main Authors Hadano, Yasuyuki, MD, Ogawa, Hiroshi, MD, Wakeyama, Takatoshi, MD, FJCC, Takaki, Akira, MD, Iwami, Takahiro, MD, FJCC, Kimura, Masayasu, MD, Miyazaki, Yosuke, MD, Okada, Haruhiko, MD, Shimizu, Akihiko, MD, FJCC, Matsuzaki, Masunori, MD, FJCC
Format Journal Article
LanguageEnglish
Published Japan Japanese College of Cardiology 01.02.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Summary We report a case of Brugada syndrome with a high defibrillation threshold (DFT) in whom a subcutaneous array lead was used to lower the DFT in combination with a transvenous right ventricular defibrillation lead. The patient had previously received pacemaker implantation due to sick sinus syndrome. An implantable cardioverter defibrillator (ICD) with a transvenous right ventricular defibrillation lead alone required a high DFT. A subcutaneous array lead improved defibrillation efficacy in combination with a right ventricular lead. These data suggest that a subcutaneous array lead facilitates implantation of an effective ICD lead system in patients requiring a high DFT.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1878-5409
1878-5409
DOI:10.1016/j.jccase.2009.06.004